H19 Gene News and Research

RSS
Researchers find new gene in brown fat cells that may help in treatment of obesity

Researchers find new gene in brown fat cells that may help in treatment of obesity

Stem cell disease model reveals how tumor suppressor may drive bone cancer

Stem cell disease model reveals how tumor suppressor may drive bone cancer

Tikcro reports net loss of $1.0 million for third quarter 2011

Tikcro reports net loss of $1.0 million for third quarter 2011

Tikcro reports net loss of $30,000 for first quarter 2011

Tikcro reports net loss of $30,000 for first quarter 2011

BioCancell raises $5.1 million by excess demand in public offering

BioCancell raises $5.1 million by excess demand in public offering

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

Tikcro reports $3.2 million net loss for second-quarter 2010

Tikcro reports $3.2 million net loss for second-quarter 2010

Tikcro Technologies reports net income of $1.9 million for first-quarter 2010

Tikcro Technologies reports net income of $1.9 million for first-quarter 2010

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

Tikcro Technologies reports net loss of $1.8M for fourth-quarter 2009

Research leads to advanced trials of new cancer treatment

Research leads to advanced trials of new cancer treatment

Common epigenetic problem doubles cancer risk

Common epigenetic problem doubles cancer risk

A moderately high protein diet could reduce a woman’s chances of becoming pregnant

A moderately high protein diet could reduce a woman’s chances of becoming pregnant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.